PureTech Health (PRTC) Common Equity (2019 - 2023)
PureTech Health (PRTC) has disclosed Common Equity for 5 consecutive years, with $464.1 million as the latest value for Q4 2023.
- Quarterly Common Equity fell 14.41% to $464.1 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $464.1 million through Dec 2023, down 14.41% year-over-year, with the annual reading at $464.1 million for FY2023, 14.41% down from the prior year.
- Common Equity for Q4 2023 was $464.1 million at PureTech Health, down from $542.2 million in the prior quarter.
- The five-year high for Common Equity was $669.7 million in Q4 2020, with the low at $464.1 million in Q4 2023.
- Average Common Equity over 5 years is $587.5 million, with a median of $593.5 million recorded in 2021.
- The sharpest move saw Common Equity grew 0.26% in 2020, then fell 14.41% in 2023.
- Over 5 years, Common Equity stood at $668.0 million in 2019, then grew by 0.26% to $669.7 million in 2020, then decreased by 11.38% to $593.5 million in 2021, then dropped by 8.64% to $542.2 million in 2022, then dropped by 14.41% to $464.1 million in 2023.
- According to Business Quant data, Common Equity over the past three periods came in at $464.1 million, $542.2 million, and $593.5 million for Q4 2023, Q4 2022, and Q4 2021 respectively.